Similar Articles
Psychedelic Chemicals and Depression Treatment
Ayşe Zağlı, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2021.75667
Issue: 2021, Volume 2 - Issue 2
902
1218
NLRP3 Inflammasome: A New Target in Psychiatric Disorders
Sevda Çelik, Aylin Kayaaltı, Oytun Erbaş
DOI: 10.5606/jebms.2021.75681
Issue: 2021, Volume 2 - Issue 3
1340
729
Glutamate Receptor Activity in Neuropsychiatric Disorders
Damla Koyun, Merve Nur Sevinç, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2022.1009
Issue: 2022, Volume 3 - Issue 1
731
512
Understanding the Role of DISC1 in Psychiatric Disorders
Şeyda Yazıcı, Hadi Sasani, Oytun Erbaş
DOI: 10.5606/jebms.2022.1011
Issue: 2022, Volume 3 - Issue 1
914
534
Human Prefrontal Cortex: Regions and Functions
Ece Sarı, Oytun Erbaş
DOI: 10.5606/jebms.2022.1020
Issue: 2022, Volume 3 - Issue 2
1637
805
Evidence for Genetic Relationships in Attention-Deficit Hyperactivity Disorder
Büşra Candan Balkan, Kerem Can Tunç, Oytun Erbaş
DOI: 10.5606/jebms.2022.1036
Issue: 2022, Volume 3 - Issue
539
504
Mental Health Disorders Associated with Bartonella spp. and Toxoplasma gondii
Kerem Can Tunç,Oytun Erbaş
DOI: 10.5606/jebms.2022.1037
Issue: 2022, Volume 3 - Issue
2437
788
Non-Coding RNAs in Brain Function and Disorders
Buse Kaptan, Mai Abusalim, Oytun Erbaş
DOI: 10.5606/jebms.2023.1042
Issue: 2023, Volume 4 - Issue 1
471
488
Endoplasmic Reticulum Stress: Implications for Psychiatric Disorders
Ecren Büyükada, Ejder Saylav Bora, İlknur Altuntaş, Oytun Erbaş
DOI: 10.5606/jebms.2023.1044
Issue: 2023, Volume 4 - Issue 1
669
451